Doxorubicin

EPH receptor A2 ; Homo sapiens







4 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 35217483 Understanding nanomedicine treatment in an aggressive spontaneous brain cancer model at the stage of early blood brain barrier disruption. 2022 Apr 1
2 29392452 YSA-conjugated mesoporous silica nanoparticles effectively target EphA2-overexpressing breast cancer cells. 2018 Apr 2
3 29110283 EphA2 Targeted Doxorubicin-Nanoliposomes for Osteosarcoma Treatment. 2017 Dec 2
4 19724921 Biological significance of EPHA2 expression in neuroblastoma. 2009 Oct 1